ES2177530T3 - Vacunas contra el virus de la leucemia felina. - Google Patents

Vacunas contra el virus de la leucemia felina.

Info

Publication number
ES2177530T3
ES2177530T3 ES92922254T ES92922254T ES2177530T3 ES 2177530 T3 ES2177530 T3 ES 2177530T3 ES 92922254 T ES92922254 T ES 92922254T ES 92922254 T ES92922254 T ES 92922254T ES 2177530 T3 ES2177530 T3 ES 2177530T3
Authority
ES
Spain
Prior art keywords
leukemia virus
feline leukemia
vaccines against
presented
recombinants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922254T
Other languages
English (en)
Inventor
Richard Calvert Wardley
Darrell Ray Thomsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2177530T3 publication Critical patent/ES2177530T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTAN BACULOVIRUS RECOMBINANTES QUE EXPRESAN LOS GENES QUE SE ENCUENTRAN ENTRE EL GP70 Y GP85 DEL VIRUS DE LA LEUCEMIA FELINA. TAMBIEN SE PRESENTAN LAS VACUNAS BASADAS EN PROTEINAS EXPRESADAS A PARTIR DE ESTOS RECOMBINANTES. TAMBIEN SE PRESENTA UN METODO DE INOCULACION MUCOSO/PARENTERAL COMBINADO.
ES92922254T 1991-11-08 1992-10-08 Vacunas contra el virus de la leucemia felina. Expired - Lifetime ES2177530T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78916391A 1991-11-08 1991-11-08
US85706492A 1992-03-25 1992-03-25

Publications (1)

Publication Number Publication Date
ES2177530T3 true ES2177530T3 (es) 2002-12-16

Family

ID=27120881

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92922254T Expired - Lifetime ES2177530T3 (es) 1991-11-08 1992-10-08 Vacunas contra el virus de la leucemia felina.

Country Status (12)

Country Link
EP (2) EP0611397B1 (es)
JP (1) JP2852395B2 (es)
KR (1) KR100265393B1 (es)
AT (1) ATE219520T1 (es)
AU (2) AU672372B2 (es)
CA (1) CA2120137C (es)
DE (1) DE69232650T2 (es)
DK (1) DK0611397T3 (es)
ES (1) ES2177530T3 (es)
LV (1) LV13060B (es)
MX (1) MX9206018A (es)
WO (1) WO1993009238A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593669A (en) * 1992-04-29 1997-01-14 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle
US6090379A (en) * 1992-04-29 2000-07-18 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle for use in recombinant protein production and pesticides
DE69333051T2 (de) * 1992-04-29 2004-04-29 Boyce Thompson Institute For Plant Research, Inc. Mundinfektion der insektlarven mit prä-okkludierten bakuloviruspartikeln
FR2715664B1 (fr) * 1994-01-31 1996-04-12 Proteine Performance Sa Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
DE69535669T2 (de) 1994-05-09 2008-12-04 Oxford Biomedica (Uk) Ltd. Retrovirale vektoren mit verminderter rekombinationsrate
US6248582B1 (en) * 1997-10-08 2001-06-19 Imran Khan Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV
KR20190062084A (ko) 2017-11-28 2019-06-05 주식회사 제트바이오텍 고양이 백혈병 바이러스 검출용 프라이머 및 이를 포함한 진단 키트
CN109679970B (zh) * 2018-11-20 2020-12-08 杭州贤至生物科技有限公司 猫疱疹i型病毒快速检测的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173997A1 (en) * 1984-09-06 1986-03-12 Chiron Corporation Feline leukemia virus protein vaccines and their preparation
AU607399B2 (en) * 1985-09-09 1991-03-07 Cetus Corporation Infectious recombinant virus vaccine for feline leukemia
ZA867281B (en) * 1985-09-25 1987-05-27 Oncogen Vaccines and immunoassays for acquired immune deficiency syndrome
NZ217645A (en) * 1985-09-25 1991-11-26 Oncogen Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations
GB8523999D0 (en) * 1985-09-30 1985-11-06 Jabay Ltd Injection of liquid into meat
AU607427B2 (en) * 1986-05-30 1991-03-07 Cambridge Bioscience Corporation Method of preparation and use for feline leukemia virus antigens
EP0427788B1 (en) * 1988-08-08 1995-11-22 The Upjohn Company Methods for isolating herpes virus thymidine kinase-encoding dna
HUT60506A (en) * 1989-11-20 1992-09-28 Oncogen Process for producing non-replicable, recombinant retrovirus particles and antiviral and immunogenic preparations

Also Published As

Publication number Publication date
AU689355B2 (en) 1998-03-26
AU2892392A (en) 1993-06-07
KR100265393B1 (ko) 2000-10-02
DK0611397T3 (da) 2002-10-07
EP0611397B1 (en) 2002-06-19
EP1136562A3 (en) 2003-06-25
DE69232650D1 (de) 2002-07-25
AU4213496A (en) 1996-04-26
JPH06510910A (ja) 1994-12-08
JP2852395B2 (ja) 1999-02-03
MX9206018A (es) 1993-05-01
ATE219520T1 (de) 2002-07-15
AU672372B2 (en) 1996-10-03
WO1993009238A1 (en) 1993-05-13
LV13060B (en) 2003-12-20
DE69232650T2 (de) 2002-11-28
EP0611397A1 (en) 1994-08-24
EP1136562A2 (en) 2001-09-26
CA2120137A1 (en) 1993-05-13
CA2120137C (en) 2004-05-04

Similar Documents

Publication Publication Date Title
ES2059370T3 (es) Un virus herpes simplex recombinante, vacunas y metodos.
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
CA2243570A1 (en) Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv
ATE184613T1 (de) Varianten des grünen fluoreszenzproteins, gfp
ATE152355T1 (de) Rekombinante herpes simplex virus impfstoffe und methoden
ES2143507T3 (es) Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia.
IT1182179B (it) Supporto regolabile per apparecchi aspiratori di fumi esalazioni e simili
CO4960659A1 (es) Vacuna que comprende un antigeno de virus de la hepatitis b y un antigeno del virus herpes simplex
ES522762A0 (es) "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"
GR880100761A (el) Αναπαραγωγή και μετασχηματισμός του βάμβακος.
CY1108240T1 (el) ΑΠΟΜΟΝΩΜΕΝΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΤΑ ΟΠΟΙΑ ΕΧΟΥΝ ΕΝΑ ΜΕΙΩΜΕΝΟ ΠΕΡΙΕΧΟΜΕΝΟ ΜΟΤΙΒΩΝ 5΄CpG3΄ ΕΠΙΓΕΝΕΤΙΚΟΥ ΕΛΕΓΧΟΥ ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ
DE68906054D1 (de) Hyperimmunizierte milch gegen bluthochdruck.
KR890000667A (ko) 외래성 dna를 메틸 영양 요구성 세균에서 발현시키기 위한 프로모터, 이의 제조방법 및 이의 용도
CA2120137A1 (en) Feline leukemia virus vaccines
FI102376B (fi) Rebekkamysiinin analogeja tryptofaanin analogien syötön avulla
ATE121136T1 (de) Effizientes verfahren zur nachweisbaren expression nichtselektierbarer gene.
DK76688D0 (da) Vaccine indeholdende f-proteinet fra aids-virus
FI98467B (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
EP0623172A4 (en) RECOMBINANT POXVIRUS AS A VACCINE AGAINST THE VIRUS OF MAREK DISEASE.
ES2191681T3 (es) Promotores sinteticos de virus de herpes simple.
DE3862473D1 (de) Farbkathodenstrahlroehre.
ES2094088B1 (es) Identificacion, clonacion y utilizacion de una region de dna amplificada en cepas de p. chrysogenum superproductoras de penicilina.
ATE92954T1 (de) Einrichtung zum kultivieren von autotrophen mikroorganismen.
ES2120620T3 (es) Tiazoles antivirales.
DE3866895D1 (de) Farbkathodenstrahlroehre.